INFERTILITY TREATMENT MARKET SIZE TO CROSS USD 7 BILLION BY 2024, GROWING AT A CAGR OF OVER 6% DURING FORECAST PERIOD

Infertility Treatment Market Size, Share, & Trends Analysis Report by Product (Drugs (Gonadotropins and Other Drugs) and Devices (Equipment, Media, and Consumables)), Procedure (Drug Therapy, ART Procedure, and Surgical Intervention), End-user (Clinics, Hospitals, Gynecological & Urology Clinics, and Others), Cause (Female and Male), and Geography (APAC, North America, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019–2024

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

327 Pages

icon-table

59 Tables

icon-chart

173 Charts

icon-region

5 Regions

icon-country

16 Countries

icon-company

20 Companies

icon-market

5 Market Segment

INFERTILITY TREATMENT MARKET REPORT SCOPE

Report Attribute Details
Market Size (Revenue) USD 7 Billion (2024)
CAGR 6% (2019-2024)
Base Year 2018
Forecast Year 2019- 2024
Market Segments Product (Drugs (Gonadotropins and Other Drugs) and Devices (Equipment, Media, and Consumables)), Procedure (Drug Therapy, ART Procedure, and Surgical Intervention) End-user (Clinics, Hospitals, Gynecological & Urology Clinics, and Others), Cause (Female and Male)
Geographic Analysis Europe, North America, APAC, Latin America, and Middle East & Africa
Countries Covered Spain, France, Germany, UK, Italy, Canada, US, China, Japan, South Korea, India, Australia, Brazil, Argentina, Mexico, Turkey, and Israel

INDUSTRY INSIGHTS

The global infertility treatment market size will reach USD 7 billion in 2025, growing at a CAGR of 6% during the forecast period. The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide. Hence, the treatment is likely to grow at a healthy rate due to attractive long-term growth from favorable demographics and social/cultural shifts.

Over the past few years, the infertility treatment market has been growing at a healthy rate. This growth is due to the growing awareness of several medical care options, IVF procedures, and the surge in fertility tourism. The popularity of same-sex marriage in the US increases the adoption of several assisted reproductive technology (ART) procedures.

The rise in the obese population is also positively influencing the growth of infertility treatment. Obesity might lead to ovulation disorder, imbalance in hormones, and, eventually, result in infertility. This increase in infertility has contributed to driving market growth globally.

SNIPPETS

  • The increasing acceptance of advanced and sophisticated medical care options such as ART and IVF is likely to drive the market.
  • The globalization of healthcare facilities and the increasing popularity of fertility tourism. This is encouraging several couples to travel abroad to seek state-of-the-art medical care options.
  • The reimbursement coverage is also improving globally, and many countries cover fertility treatment as part of respective public health coverage programs.
  • Most fertility service providers offer discounted programs and flexible payment options. These are promotional initiatives, promoting savings on expensive procedures to self-pay patients.
  • The growing popularity of fertility tourism is expected to increase the demand for medical procedures in countries where the cost is low and success rates are high, thereby driving the segment.

INFERTILITY TREATMENT MARKET SEGMENTATION

This research report includes detailed segmentation by

  • Product
  • Procedure
  • End-user
  • Cause
  • Geography

INSIGHTS BY PRODUCT

Treatment by drugs has been dominating the infertility treatment market share. This method is a cost-effective measure and is considered the first choice among people to be treated. The acceptance of gonadotropin drugs for treatment is driving the segment significantly. It is likely to witness steady growth during the forecast period.

Globally, the IVF treatments are witnessing an improvement in overall success rates majorly due to the availability of a broad range of culture media. The consumables segment is rapidly increasing. The increasing effectiveness of ART procedures and surgical interventions creates a huge demand for consumables. Therefore, the consumables segment is expected to grow by 2024.

INSIGHTS BY PROCEDURE

The medication market segment accounted for a market share of 73% in 2018. The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to high demand for medication and treatments. The awareness of sterility treatment has increased over time, thereby reducing the reluctance of people to opt for medication.

ART is the fastest growing procedure. The high acceptance rate is because of the improvement in success rate and advanced techniques to cure sterility. ART procedures include different procedures like artificial insemination, in-vitro fertilization IVF, surrogacy, and others. The favorable financial support for ART procedures in both developed and emerging countries is another factor contributing to the growth. However, the segment is likely to witness hindrance due to the high cost of ART procedures.

The surgical interventions segment is expected to witness gradual growth by 2024. Surgical interventions are considered as the second line of care after medication. This segment is likely to see an incremental growth of around $200 million during the forecast period. 

INSIGHTS BY END-USER

Fertility clinics dominate the market due to the high success rate of fertility services and IVF clinics. The number of fertility centers is expanding across the globe. These clinics occupy the largest share in the infertility treatment market.

Fertility centers offer different services, such as IVF programs, egg donation, ICSI, IMSI, and other services. The segment is projected to hold the highest share during the forecast period. This is due to the constant rise in clinics and increasing partnership of clinics with fertile consultants and experts.

Hospitals are a significantly fast-growing segment. They provide traditional medical care, such as fertility medicines, drugs, prescriptions, and surgeries. They also facilitate procedures such as IVF and ART, which are likely to have significant demand during the forecast period.

Gynecologists and urologist clinics offer high-quality women’s healthcare services, including labor care, and prescribe medication for fertility treatment. They are primary healthcare centers performing preliminary fertility evaluations among end-users. Hence, this segment is expected to grow at a steady growth during the forecast period.

INSIGHTS BY CAUSES

The female segment is contributing significantly to the market due to the high prevalence of female infertility globally. The increase in the target pool of female patients and the growing fertility clinics are the major factors driving the growth. The rise in the number of obese women is likely to increase the demand for various fertility treatment options.

The prevalence of male sterility is increasing worldwide due to changes in lifestyle patterns. Increase in the consumption of alcohol and smoking, and an increase in the prevalence of obesity are the responsible factors. All these factors affect sperm counts and their quality, thereby increasing the occurrence among men.

INSIGHTS BY GEOGRAPHY

Europe is leading the market and is expected to bolster its dominance during the forecast period. The region is going through a phase of reduction in population and is seriously considering tackling this sociological phenomenon. Spain, France, Germany, the UK, and Italy are the leading revenue generators. The region will witness an incremental growth of around $600 million during the forecast period.

The demand for fertility services is increasing rapidly in North America. The rise is due to the growing prevalence of sterility, the presence of the aging population, and obesity. These factors are likely to generate significant demand for fertility services in the future.

APAC is growing at a steady pace. The shifting mean age among women during their first childbirth and the increasing sterility is driving the market growth. Japan, Australia, China, and India are the major revenue contributors in the APAC region. This region is likely to witness the highest incremental revenues during the forecast period.

Latin America is witnessing a rise in sterility among men and women. The decreasing fertility rates in the population is likely to increase the demand for fertility services. The region is growing at a moderate pace, which is likely to continue during the forecast period.

MEA faces a low healthcare facility, a lack of specialized health care professionals, and inadequate awareness of fertility medical care. However, the growing awareness and development of advanced technology are expected to drive the infertility treatment market share in the region. 

INSIGHTS BY VENDORS

There are a few global and several local and regional key players offering medicines, devices, and treatment equipment. The fertility drug market is highly concentrated, with key pharmaceuticals accounting for commendable shares. However, the other fertility drugs market is highly fragmented. Many local and domestic companies are offering a wide array of low-cost drugs in their respective countries.

The market is competitive due to the availability of several low-cost drugs. Companies offering fertility drugs are registering impressive growth rates for their products due to the increased uptake of these drugs.

Cooper Companies offers its infertility treatment products through the CooperSurgical business segment. Cooper is focusing on specific segments of women’s health care market and is the market leader. Its major competitors in the market include Cook, Irvine Scientific, and Vitrolife.

The global infertility treatment market research report includes revenues & forecasts for the following segments:

By Product 

  • Drugs
    • Gonadotropins
    • Other Drugs
  • Devices
    • Equipment
    • Media
    • Consumables

By Procedure 

  • Drug Therapy
  • ART Procedure
  • Surgical Intervention

By End-user

  • Clinics
  • Hospitals
  • Gynecological & Urology Clinics
  • Others

By Cause  

  • Female
  • Male
  • Others

By Geography

  • Europe
    • Spain
    • France
    • Germany
    • UK
    • Italy
  • North America
    • Canada
    • US
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Turkey
    • Israel

Frequently Asked Questions

What is the Infertility Treatment Market size and growth rate during the forecast period?

The global infertility treatment market size to cross USD 7 billion by 2024, growing at a CAGR of over 6 during 2020-2025

What are the factors impacting the growth of the Infertility Treatment Market share?

The growing prevalence of infertility among men and women is increasing the demand for sterility treatment globally. Factors such as delayed parenthood, sexually transmitted infections (STIs), and aging is increasing sterility incidences among married couples worldwide

How is the growth prospects of the infertility treatment market in Europe?

Europe is leading the market and is expected to bolster its dominance during the forecast period.

Who are the leading vendors and what is their market share?

The leading vendors in the global infertility treatment market are: The Cooper Companies, Cook Medical, Vitrolife, Ferring Pharmaceuticals, IVFtech, Irvine Scientific, and Merck KGaA

What is the growth of the medication segment during the forecast period?

The medication market segment accounted for a market share of 73% in 2018. The medication segment is the largest contributor due to a wide range and usage. The increasing approval of fertility services and cultural shifts has led to high demand for medication and treatments.

Download Free Sample

The infertility treatment market is expected to grow at a CAGR of over 6% during the forecast period 2018–2024.

 The following factors are likely to contribute to the growth of the infertility treatment market during the forecast period:

  • Increasing Prevalence of Infertility
  • Growing Number of Obesity Cases
  • Increasing Number of Facilities offering Fertility Services
  • Increasing Financial Assistance Programs
  • Growing popularity for Fertility Tourism

 Base Year:                  2018

Forecast Year:           2019–2024

The study considers the present scenario of the global infertility treatment market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.

Key Vendors

  • The Cooper Companies
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Cook Medical
  • Vitrolife
  • Ferring Pharmaceuticals
  • IVFtech
  • Irvine Scientific
  • Merck KGaA

 Other Vendors

  • Abbott
    • Business Overview
    • Major Product Offerings
  • Sanofi
  • Salix Pharmaceuticals
  • Microtech IVF
  • Novartis
  • Hamilton Thorne
  • The Merck Co
  • Thermo Fisher Scientific
  • INVO Bioscience
  • MedGyn Products
  • SOMATEX Medical Technologies
  • CARL ZEISS

Market Segmentation by Product 

  • Drugs
    • Gonadotropins
    • Other Drugs
  • Devices
    • Equipment
    • Media
    • Consumables

Market Segmentation by Procedure  

  • Drug Therapy
  • ART Procedure
  • Surgical Intervention

Market Segmentation by End-user

  • Infertility Clinics
  • Hospitals
  • Gynecological & Urology Clinics
  • Others

Market Segmentation by Cause   

  • Female Infertility
  • Male Infertility
  • Others

Market Segmentation by Geography

  • Europe
    • Spain
    • France
    • Germany
    • UK
    • Italy
  • North America
    • Canada
    • US
  • APAC
    • China
    • Japan
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • MEA
    • Turkey
    • Israel

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of the study

4.4 Market Segments

4.4.1 Market Segmentation by Products

4.4.2 Market Segmentation by Infertility Cause

4.4.3 Market Segmentation by Procedure

4.4.4 Market Segmentation by End-users

4.4.5 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Infertility: An Overview

7.1.1 Symptoms

7.1.2 Causes

7.1.3 Infertility Treatment

7.2 Infertility Treatment: Global Market Snapshot

7.2.1 Overview

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Increasing Prevalence of Infertility

8.1.2 Rising Number of Obesity Cases

8.1.3 Increasing Acceptance of ART Procedures

8.1.4 Increasing Number of Facilities Offering Fertility Services

8.2 Market Growth Restraints

8.2.1 High Cost of Infertility Treatment

8.2.2 Lack of Standardized Government Regulations on Treatment

8.2.3 Ethical Challenges Related to Treatment

8.2.4 Limitations & Risks Associated with Treatment

8.3 Market Opportunities & Trends

8.3.1 Financial Assistance Programs & Employer Benefits for Treatment

8.3.2 Growing Popularity of Fertility/Reproductive Tourism

8.3.3 Technological Advancements & Innovations

8.3.4 Acceptance of Infertility Treatment in Single Parents & Same-Sex Couples

9 Global Infertility Treatment Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 Infertility Treatment Market by Product

10.1 Market Snapshot & Growth Engine

10.2 Market Overview

11 Infertility Treatment Market by Drugs

11.1 Market Overview

11.1.1 Market Size & Forecast

11.2 Gonadotropins

11.2.1 Market Overview

11.2.2 Market Size & Forecast

11.3 Other Drugs

11.3.1 Market Overview

11.3.2 Market Size & Forecast

11.4 Infertility Drugs: Market Segmentation by Region

11.4.1 Overview

12 Infertility Treatment Market by Devices

12.1 Market Overview

12.1.1 Market Size & Forecast

12.2 Equipment

12.2.1 Market Overview

12.2.2 Market Size & Forecast

12.3 Media

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.4 Consumables & Accessories

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.5 Infertility Treatment Devices: Segmentation by Region

12.5.1 Overview

13 Infertility Treatment Market by Cause

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Female Infertility

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.4 Male Infertility

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.5 Other Types of Infertility

13.5.1 Market Overview

13.5.2 Market Size & Forecast

14 Infertility Treatment Market by Procedure

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Medication

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.4 Assisted Reproductive Treatment

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.5 Surgical Intervention

14.5.1 Market Overview

14.5.2 Market Size & Forecast

15 Infertility Treatment Market by End-User

15.1 Market Snapshot & Growth Engine

15.2 Market Overview

15.3 Fertility Clinics

15.3.1 Market Overview

15.3.2 Market Size & Forecast

15.4 Hospitals

15.4.1 Market Overview

15.4.2 Market Size & Forecast

15.5 Gynecology & Urology Clinics

15.5.1 Market Overview

15.5.2 Market Size & Forecast

15.6 Other End-users

15.6.1 Market Overview

15.6.2 Market Size & Forecast

16 Infertility Treatment Market by Geography

16.1 Market Snapshot & Growth Engine

16.2 Market Overview

17 Europe

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Market Segmentation by Product Type

17.3.1 Overview

17.4 Key Countries

17.4.1 Spain: Market Size & Forecast

17.4.2 France: Market Size & Forecast

17.4.3 Germany: Market Size & Forecast

17.4.4 UK: Market Size & Forecast

17.4.5 Italy: Market Size & Forecast

18 North America

18.1 Market Overview

18.2 Market Size & Forecast

18.3 Market Segmentation by Product Type

18.3.1 Overview

18.4 Key Countries

18.4.1 US: Market Size & Forecast

18.4.2 Canada: Market Size & Forecast

19 APAC

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Market Segmentation by Product Type

19.3.1 Overview

19.4 Key Countries

19.4.1 Japan: Market Size & Forecast

19.4.2 Australia: Market Size & Forecast

19.4.3 China: Market Size & Forecast

19.4.4 India: Market Size & Forecast

20 Latin America

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Market Segmentation by Product Type

20.3.1 Overview

20.4 Key Countries

20.4.1 Brazil: Market Size & Forecast

20.4.2 Argentina: Market Size & Forecast

20.4.3 Mexico: Market Size & Forecast

21 Middle East & Africa

21.1 Market Overview

21.2 Market Size & Forecast

21.3 Market Segmentation by Product Type

21.3.1 Overview

21.4 Key Countries

21.4.1 Turkey: Market Size & Forecast

21.4.2 Israel: Market Size & Forecast

22 Competitive Landscape

22.1 Competition Overview

22.2 Vendors Market Share Analysis

22.2.1 The Cooper Companies

22.2.2 Cook Medical

22.2.3 Vitrolife

22.2.4 Ferring Pharmaceuticals

22.2.5 Merck KGaA

22.2.6 IVFtech

23 Key Company Profiles

23.1 The Cooper Companies

23.1.1 Business Overview

23.1.2 Major Product Offerings

23.1.3 Key Strengths

23.1.4 Key Strategies

23.1.5 Key Opportunities

23.2 Cook Medical

23.2.1 Business Overview

23.2.2 Major Product Offerings

23.2.3 Key Strengths

23.2.4 Key Strategies

23.2.5 Key Opportunities

23.3 Vitrolife

23.3.1 Business Overview

23.4 Major Product Offerings

23.4.1 Key Strengths

23.4.2 Key Strategies

23.4.3 Key Opportunities

23.5 Ferring Pharmaceuticals

23.5.1 Business Overview

23.5.2 Major Product Offerings

23.5.3 Key Strengths

23.5.4 Key Strategies

23.5.5 Key Opportunities

23.6 IVFtech

23.6.1 Business Overview

23.6.2 Major Product Offerings

23.6.3 Key Strengths

23.6.4 Key Strategies

23.6.5 Key Opportunities

23.7 FUJIFILM Irvine Scientific

23.7.1 Business Overview

23.7.2 Major Product Offerings

23.7.3 Key Strengths

23.7.4 Key Strategies

23.7.5 Key Opportunities

23.8 Merck KGaA

23.8.1 Business Overview

23.8.2 Major Product Offerings

23.8.3 Key Strengths

23.8.4 Key Strategies

23.8.5 Key Opportunities

24 Other Prominent Vendors

24.1 Abbott

24.1.1 Business Overview

24.1.2 Major Product Offerings

24.2 Sanofi

24.2.1 Business Overview

24.2.2 Major Product Offerings

24.3 Salix Pharmaceuticals

24.3.1 Business Overview

24.3.2 Major Product Offerings

24.4 Microtech IVF

24.4.1 Business Overview

24.4.2 Major Product Offering

24.5 Novartis

24.5.1 Business Overview

24.5.2 Major Product Offerings

24.6 Hamilton Thorne

24.6.1 Business Overview

24.6.2 Major Product Offering

24.7 Merck Co

24.7.1 Business Overview

24.7.2 Major Product Offerings

24.8 Thermo Fisher Scientific

24.8.1 Business Overview

24.8.2 Major Product Offerings

24.9 INVO Bioscience

24.9.1 Business Overview

24.9.2 Major Product Offerings

24.10 MedGyn Products

24.10.1 Business Overview

24.10.2 Major Product Offerings

24.11 SOMATEX Medical Technologies

24.11.1 Business Overview

24.11.2 Major Product Offerings

24.12 Carl Zeiss

24.12.1 Business Overview

24.12.2 Major Product Offerings

25 Report Summary

25.1 Key Takeaways

25.2 Strategic Recommendations

25.3 Quantitative Summary

25.3.1 By Product

25.3.2 By Procedure

25.3.3 By Infertility Cause

25.3.4 By End-user

25.3.5 By Geography

25.3.6 By Drugs

25.3.7 By Devices

26 Appendix

26.1 Abbreviations

List of Exhibits 

Exhibit 1               Segmentation of Global Infertility Treatment Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               5-year Primary Infertility Rate Among Males & Females

Exhibit 4               5-year Secondary Infertility Rate Among Males & Females

Exhibit 5               Causes of Infertility

Exhibit 6               Global Infertility Treatment Market by Product 2018 (%)

Exhibit 7               Global Infertility Treatment Market by Geography 2018 (%)

Exhibit 8               Impact of Increasing Prevalence of Infertility

Exhibit 9               Couples Affected by Infertility Worldwide from 1990−2010 (million)

Exhibit 10             Six Demographic Realities of Infertility

Exhibit 11             Share of Primary and Secondary Fertility Among Couples Worldwide

Exhibit 12             Cause of Infertility Among Couples by Region 2015 (%)

Exhibit 13             Percentage of Infertile Married Women in US 2002−2015

Exhibit 14             Share of Infertile Women with Infection-related Diagnosis by Region

Exhibit 15             Mean Age of Women Having Their First Child in Developed and Developing Countries

Exhibit 16             Impact of Rising Number of Obesity Cases

Exhibit 17             Number of Obese Adults by Gender 2016 (million)

Exhibit 18             Prevalence Rate of Obesity in Men and Women 2016

Exhibit 19             Worldwide Number of Obese Adults 1975 Versus 2016 (million)

Exhibit 20             Worldwide Prevalence of Obesity Among Adults by Region 2016

Exhibit 21             Impact of Increasing Acceptance of ART Procedures

Exhibit 22             Global Number of ART Cycles Performed 2007 Versus 2018

Exhibit 23             Number of ART Cycles Performed by Region 2018

Exhibit 24             Impact of Increasing Number of Facilities Offering Fertility Services

Exhibit 25             Percentage Share of ART Cycles Performed by Region 2018

Exhibit 26             Share of Stand-alone Fertility Care Centers by Region 2017

Exhibit 27             Impact of High Cost of Treatment

Exhibit 28             Average Cost of Single IVF Cycle in Various Countries ($)

Exhibit 29             Impact of Lack of Standardized Government Regulations on Treatment

Exhibit 30             Major Legal Differences Between Countries for Treatment

Exhibit 31             Impact of Ethical Challenges Related to Treatment

Exhibit 32             Impact of Limitations & Risks Associated with Treatment

Exhibit 33             Limitations & Risks Associated with Treatment

Exhibit 34             Cumulative Pregnancy Rate of IVF Procedure

Exhibit 35             Impact of Financial Assistance Programs & Employer Benefits for Treatment

Exhibit 36             Impact of Growing Popularity of Fertility/Reproductive Tourism

Exhibit 37             Factors Influencing Patients to Consider Fertility Tourism

Exhibit 38             Impact of Technological Advancements & Innovations

Exhibit 39             Impact of Acceptance of Treatment in Single Parents & Same-Sex Couples

Exhibit 40             Same-Sex Married Couples in US Between 2004-2014 Period

Exhibit 41             Global Infertility Treatment Market 2018−2024 ($ million)

Exhibit 42             Market by Procedure

Exhibit 43             Market by Product Type

Exhibit 44             Market by Geography

Exhibit 45             Market by Cause

Exhibit 46             Market by End-users

Exhibit 47             Five Forces Analysis 2018

Exhibit 48             Incremental Growth by Product 2018–2024

Exhibit 49             Market by Product

Exhibit 50             Market by Product 2018−2024 ($ million)

Exhibit 51             Market by Product 2018−2024 (%)

Exhibit 52             Global Infertility Drugs Treatment Market 2018−2024 ($ million)

Exhibit 53             Global Gonadotropins Market 2018-2024 ($ million)

Exhibit 54             Global Infertility Other Drugs Treatment Market 2018-2024 ($ million)

Exhibit 55             Market by Region 2018 & 2024 (%)

Exhibit 56             Market by Region 2018-2024 ($ million)

Exhibit 57             Market by Region 2018-2024 (%)

Exhibit 58             Global Infertility Devices Market 2018−2024 ($ million)

Exhibit 59             Global Infertility Equipment Market 2018-2024 ($ million)

Exhibit 60             Global Infertility Treatment Media Market 2018-2024 ($ million)

Exhibit 61             Global Infertility Treatment Consumables & Accessories Market 2018-2024 ($ million)

Exhibit 62             Market by Region 2018 & 2024 (%)

Exhibit 63             Market by Region 2018-2024 ($ million)

Exhibit 64             Market by Region 2018-2024 (%)

Exhibit 65             Incremental Growth by Cause 2018-2024

Exhibit 66             Market by Cause

Exhibit 67             Market by Cause 2018 & 2024 (%)

Exhibit 68             Market by Cause 2018−2024 ($ million)

Exhibit 69             Market by Cause 2018−2024 (%)

Exhibit 70             5-year Female Factor Contribution to Primary Infertility Cases

Exhibit 71             Global Female Infertility Treatment Market 2018−2024 ($ million)

Exhibit 72             5-year Female Factor Contribution to Secondary Infertility Cases

Exhibit 73             5-year Male Factor Contribution to Primary Infertility Cases

Exhibit 74             Percentage Share of Major Causes of Male Infertility

Exhibit 75             5-year Male Factor Contribution to Secondary Infertility Cases

Exhibit 76             Global Male Infertility Treatment Market 2018−2024 ($ million)

Exhibit 77             Global Other Infertility Treatment Market 2018−2024 ($ million)

Exhibit 78             Percentage Share of Couples Reported Infertile by Region

Exhibit 79             Incremental Growth by Procedure 2018−2024

Exhibit 80             Market by Procedure

Exhibit 81             Market by Procedure 2018 & 2024 (%)

Exhibit 82             Market by Procedure 2018−2024 ($ million)

Exhibit 83             Market by Procedure 2018−2024 (%)

Exhibit 84             Global Infertility Medication Market 2018−2024 ($ million)

Exhibit 85             Adults with Obesity Worldwide

Exhibit 86             Cost Comparison of IVF and Surrogacy

Exhibit 87             Global ART Infertility Treatment Market 2018−2024 ($ million)

Exhibit 88             Global Infertility Surgical Intervention Market 2018−2024 ($ million)

Exhibit 89             Incremental Growth by End-users 2018−2024

Exhibit 90             Market by End-user

Exhibit 91             Market by End-user 2018 & 2024 (%)

Exhibit 92             Market by End-user 2018−2024 ($ million)

Exhibit 93             Market by End-user 2018−2024 (%)

Exhibit 94             Global Fertility Clinics Market 2018−2024 ($ million)

Exhibit 95             Global Infertility Treatment Hospitals Market 2018−2024 ($ million)

Exhibit 96             Global Infertility Gynecology Clinic Market 2018−2024 ($ million)

Exhibit 97             Global Other Infertility Treatment Market 2018−2024 ($ million)

Exhibit 98             Incremental Growth by Geography 2018−2024

Exhibit 99             Market by Region

Exhibit 100          Market by Region 2018 & 2024 (%)

Exhibit 101          Market by Region 2018−2024 ($ million)

Exhibit 102          Market by Region 2018−2024 (%)

Exhibit 103          Market in Europe: Key Countries Share 2018 (%)

Exhibit 104          Percentage Share of Certified IVF & Fertility Clinics by Region 2018

Exhibit 105          Market in Europe 2018–2024 ($ million)

Exhibit 106          Market in Europe by Product 2018 & 2024 (%)

Exhibit 107          Market in Europe by Product 2018-2024 (%)

Exhibit 108          Market in Europe by Product 2018-2024 (%)

Exhibit 109          Incremental Growth in Europe 2018−2024

Exhibit 110          Market in Spain 2018–2024 ($ million)

Exhibit 111          Market in France 2018–2024 ($ million)

Exhibit 112          Market in Germany 2018–2024 ($ million)

Exhibit 113          Market in UK 2018–2024 ($ million)

Exhibit 114          Market in Italy 2018–2024 ($ million)

Exhibit 115          Market in North America: Key Countries Share 2018 (%)

Exhibit 116          Percentage Share of ART Cycles Performed in North America by Countries 2018

Exhibit 117          Infertility Rate Among Women Based on Age in North America 2018 (%)

Exhibit 118          Percentage of Infertile Married Women in 15−44 Age Group

Exhibit 119          Market in North America 2018–2024 ($ million)

Exhibit 120          Market in North America by Product 2018 & 2024 (%)

Exhibit 121          Market in North America by Product 2018-2024 (%)

Exhibit 122          Market in North America by Product 2018-2024 (%)

Exhibit 123          Incremental Growth in North America 2018−2024

Exhibit 124          Share of Adult People with Obesity in US 2012

Exhibit 125          Estimated Share of Adult People with Obesity in US 2030

Exhibit 126          Market in US 2018–2024 ($ million)

Exhibit 127          Number of Infants Born and ART Procedures Performed in US (2002−2012)

Exhibit 128          Percentage Share of ART Cycles Based on Age Group 2018 (%)

Exhibit 129          Market in Canada 2018–2024 ($ million)

Exhibit 130          Market in APAC: Key Countries Share 2018 (%)

Exhibit 131          Percentage Share of ARTs Performed in Various Regions

Exhibit 132          Market in APAC 2018–2024 ($ million)

Exhibit 133          Market in APAC by Product 2018 & 2024 (%)

Exhibit 134          Market in APAC by Product 2018-2024 (%)

Exhibit 135          Market in APAC by Product 2018-2024 ($million)

Exhibit 136          Incremental Growth in APAC 2018−2024

Exhibit 137          Market in Japan 2018–2024 ($ million)

Exhibit 138          Market in Australia 2018–2024 ($ million)

Exhibit 139          Market in China 2018–2024 ($ million)

Exhibit 140          Market in India 2018–2024 ($ million)

Exhibit 141          Market in Latin America: Key Countries Share 2018 (%)

Exhibit 142          Lifetime Births Per Women in Key Latin American Countries

Exhibit 143          Market in Latin America 2018–2024 ($ million)

Exhibit 144          Market in Latin America by Product 2018 & 2024 (%)

Exhibit 145          Market in Latin America by Product 2018-2024 ($million)

Exhibit 146          Market in Latin America by Product 2018-2024 (%)

Exhibit 147          Incremental Growth in Latin America 2018−2024

Exhibit 148          Market in Brazil 2018–2024 ($ million)

Exhibit 149          Market in Argentina 2018–2024 ($ million)

Exhibit 150          Market in Mexico 2018–2024 ($ million)

Exhibit 151          Market in MEA: Key Countries Share 2018 (%)

Exhibit 152          Market in MEA 2018–2024 ($ million)

Exhibit 153          Market in MEA by Product 2018 & 2024 (%)

Exhibit 154          Market in MEA by Product 2018-2024 ($ million)

Exhibit 155          Market in MEA by Product 2018-2024 (%)

Exhibit 156          Incremental Growth in MEA 2018−2024

Exhibit 157          Market in Turkey 2018–2024 ($ million)

Exhibit 158          Market in Israel 2018–2024 ($ million)

Exhibit 159          CooperSurgical Revenue Breakdown by category FY2018 (%)

Exhibit 160          Vitrolife Sales Breakdown by Business Segment 2018

Exhibit 161          Merck KGaA Fertility Product Line Revenue 2018 & 2017 ($ million)

Exhibit 162          The Cooper Companies Sales Revenue 2018-2016 ($ million)

Exhibit 163          The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)

Exhibit 164          The Cooper Companies Sales Revenue by Business Segment 2018 & 2017 ($ million)

Exhibit 165          The Cooper Companies R&D Expenditure 2016-2018 ($ million)

Exhibit 166          Vitrolife Sales Revenue 2018–2016 ($ million)

Exhibit 167          Vitrolife Sales Revenue by Business Segment 2018 & 2017 ($ million)

Exhibit 168          Vitrolife Sales Breakdown by Business Segment 2018

Exhibit 169          Vitrolife Sales Breakdown by Geography 2018

Exhibit 170          Merck KGaA Sales Revenue 2016−2018 ($ million)

Exhibit 171          Merck KGaA Sales Revenue by Business Segments 2018 & 2017 ($ million)

Exhibit 172          Merck KGaA Sales Breakdown by Business Segment 2018

Exhibit 173          Merck KGaA Sales Breakdown by Geography 2018

               

List of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2018

Table 3                  Effects of Adipokines on Reproduction

Table 4                  Chances of a Live Birth by Fifth IVF Cycle

Table 5                  Cost of Various Treatment Options

Table 6                  Estimated Cost of IVF Treatment in Various Countries

Table 7                  Ethical and Legal Challenges Prevailing in Various Countries

Table 8                  Pregnancy Rate Among Women Undergoing IVF

Table 9                  Pregnancy Rate Among Women Undergoing ICSI

Table 10               Pregnancy Rate Among Women Donor Eggs & Embryos

Table 11               Financial Assistance Programs for Treatment

Table 12               Major Destinations for Fertility Tourism

Table 13               New Developments/Advancements in Treatment

Table 14               List of Major Countries Allowing Same-sex Marriage

Table 15               Available Treatment Options for Single Women to Conceive

Table 16               Popular Infertility Treatment Drugs Commercially Available

Table 17               Different Types of Microscopes used in ART Procedures

Table 18               Different Types of Imaging Modalities Used in ART Procedures

Table 19               Mean Age of Women at First Birth by Key Countries

Table 20               Major Drugs Prescribed for Infertility

Table 21               Global List of Popular Fertility Clinics

Table 22               List of Popular Cryobanks Offering Storage of Sperms, Eggs, and Embryos

Table 23               Competitive Structure Analysis of Global Infertility Treatment Market 2018

Table 24               Global Infertility Treatment Market by Drugs: Key Vendors Ranking 2018

Table 25               Global Infertility Treatment Market by Devices: Key Vendors Ranking 2018

Table 26               The Cooper Companies: Product Offerings

Table 27               Cook Medical: Fields of Applications

Table 28               Cook Medical: Product Offerings

Table 29               Vitrolife: Product Offerings

Table 30               Ferring Pharmaceuticals: Product Offerings

Table 31               IVFtech: Product Offerings

Table 32               FUJIFILM Irvine Scientific: Product Offerings

Table 33               Merck KGaA: Product Offerings

Table 34               Abbott: Key Product Offerings

Table 35               Sanofi: Key Product Offerings

Table 36               Salix Pharmaceuticals: Key Product Offerings

Table 37               Microtech IVF: Key Product Offerings

Table 38               Novartis: Key Product Offerings

Table 39               Hamilton Thorne: Key Product Offerings

Table 40               Merck Co: Key Product Offerings

Table 41               Thermo Fisher Scientific: Key Product Offerings

Table 42               INVO Bioscience: Key Product Offerings

Table 43               MedGyn Products: Key Product Offerings

Table 44               SOMATEX Medical Technologies: Key Product Offerings

Table 45               CARL ZEISS: Key Product Offerings

Table 46               Market by Products ($ million)

Table 47               Market by Products (%)

Table 48               Market by Procedure ($ million)

Table 49               Market by Applications (%)

Table 50               Market by Cause ($ million)

Table 51               Market by Cause (%)

Table 52               Market by End-users ($ million)

Table 53               Market by End-users (%)

Table 54               Market by Geography ($ million)

Table 55               Market by Geography (%)

Table 56               Market by Drugs ($ million)

Table 57               Market by Drugs (%)

Table 58               Market by Devices ($ million)

Table 59               Market by Devices (%)

Select a license type that suits your business needs

single-user Single User Licence
$4000.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4500.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5500.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date